Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > The Board

View:

Post by Mole101 on May 27, 2021 9:27am

The Board

https://www.sedar.com/GetFile.do?lang=EN&docClass=13&issuerNo=00022789&issuerType=03&projectNo=03228199&docId=4971820[/img]

137

Comment

Comment by Mole101 on May 27, 2021 9:31am

Election of Directors 01. Eugene Williams 04. Richard J. Gregory, Ph.D. 03. William Wyman 06. Neil K. Warma 02. Neil Cashman, M.D. 05. Patrick D. Kirwin [/img][/quote]

140

Comment

Comment by DavidKingCanada on May 27, 2021 10:01am

Great board, hoping to see who they elect as CEO. At this point, I do not believe the disapproval of Aducanumab in June will have any major impact on SP. If approved, we will definitely see an increase, possibly a few basis points. . Curious as to what others think on Aducanumab and Biogens readiness for Approval (Swiss Lab).

181

Comment

ProMIS Neurosciences Inc